(Q45871220)

English

Prophylactic treatment of haemophilia patients with inhibitors: clinical experience with recombinant factor VIIa in European Haemophilia Centres.

scientific article published in September 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17880436%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Prophylactic treatment of haemophilia patients with inhibitors: clinical experience with recombinant factor VIIa in European Haemophilia Centres (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17880436%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

0 references

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17880436%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

author name string

M Morfini

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17880436%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

G Auerswald

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17880436%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

R A Kobelt

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17880436%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

G F Rivolta

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17880436%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

J Rodriguez-Martorell

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17880436%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

F A Scaraggi

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17880436%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

C Altisent

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17880436%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

A Borel-Derlon

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17880436%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

V Rossi

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17880436%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

publication date

1 September 2007

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17880436%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17880436%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17880436%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17880436%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

502-507

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17880436%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

The incidence of factor VIII and factor IX inhibitors in the hemophilia population of the UK and their effect on subsequent mortality, 1977-99.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01455.X

21 January 2018

Incidence of development of factor VIII and factor IX inhibitors in haemophiliacs

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01455.X

21 January 2018

Inhibitors: resolving diagnostic and therapeutic dilemmas

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01455.X

21 January 2018

Inhibitor antibodies to factor VIII and factor IX: management

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01455.X

21 January 2018

Immune tolerance: a synopsis of the international experience

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01455.X

21 January 2018

Recombinant factor VIIa in the management of surgery and acute bleeding episodes in children with haemophilia and high-responding inhibitors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01455.X

21 January 2018

Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding: a systematic review

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01455.X

21 January 2018

A comparison between prophylaxis and on demand treatment for severe haemophilia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01455.X

21 January 2018

Prospective controlled studies on prophylaxis: an Italian approach

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01455.X

21 January 2018

Practice patterns in haemophilia A therapy -- global progress towards optimal care

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01455.X

21 January 2018

Rationale for the use of high dose rFVIIa in a high-titre inhibitor patient with haemophilia B during major orthopaedic procedures

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01455.X

21 January 2018

Prophylactic recombinant factor VIIa in haemophilia patients with inhibitors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01455.X

21 January 2018

Long‐term FEIBA prophylaxis does not prevent progression of existing joint disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01455.X

21 January 2018

High dose factor VIIa improves clot structure and stability in a model of haemophilia B.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01455.X

21 January 2018

Potential role of recombinant factor FVIIa in prophylaxis in severe hemophilia patients with inhibitors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01455.X

21 January 2018

Antiapoptotic effect of coagulation factor VIIa.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01455.X

21 January 2018

FVIIa:TF induces cell survival via G12/G13-dependent Jak/STAT activation and BclXL production

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01455.X

21 January 2018

Intra-articular tissue factor/factor VII complex induces chronic arthritis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01455.X

21 January 2018

Tissue factor as a proinflammatory agent

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01455.X

21 January 2018

Role of the tissue factor pathway in synovial inflammation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01455.X

21 January 2018

Pathogenesis of hemophilic arthropathy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01455.X

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45871220&oldid=1093387654"